The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation

被引:13
作者
Suarez Fernandez, Carmen [1 ]
Gullon, Alejandra [1 ]
Formiga, Francesc [2 ]
机构
[1] Hosp Univ La Princesa, Serv Med Interna, Madrid, Spain
[2] Hosp Univ Bellvitge, Serv Med Interna, IDIBELL, Unidad Geriatr, Barcelona, Spain
关键词
atrial fibrillation; direct oral anticoagulants; dosing; elderly; STROKE PREVENTION; CLINICAL CHARACTERISTICS; JAPANESE PATIENTS; OLDER PATIENTS; BLEEDING RISK; WARFARIN; SAFETY; AGE; RIVAROXABAN; MANAGEMENT;
D O I
10.2217/cer-2019-0197
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Unless contraindicated, anticoagulant therapy should be prescribed to elderly patients with atrial fibrillation. Direct-acting oral anticoagulants (DOACs) are superior to vitamin K antagonists for preventing stroke. This, together with their higher net clinical benefit, makes DOACs the treatment of choice in this population. However, due to the concerns about bleeding and the need for dose adjustment based on clinical variables, underdosing of DOACs is common and the risk of stroke high. Drugs with more easily adjusted doses are likely associated with a lower risk of dosing errors and, therefore, a greater protective effect. Correct dosing can ensure a maximal net benefit of DOACs in elderly patients with atrial fibrillation.
引用
收藏
页码:509 / 523
页数:15
相关论文
共 97 条
  • [1] Initial rivaroxaban dosing in patients with atrial fibrillation
    Ablefoni, Kaja
    Buchholz, Alexander
    Ueberham, Laura
    Hilbert, Sebastian
    Dagres, Nikolaos
    Husser, Daniela
    Hindricks, Gerhard
    Bollmann, Andreas
    [J]. CLINICAL CARDIOLOGY, 2019, 42 (10) : 873 - 880
  • [2] Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world
    Alnsasra, Hilmi
    Haim, Moti
    Senderey, Adi Berliner
    Reges, Orna
    Leventer-Roberts, Maya
    Arnson, Yoav
    Leibowitz, Morton
    Hoshen, Moshe
    Avgil-Tsadok, Meytal
    [J]. HEART RHYTHM, 2019, 16 (01) : 31 - 37
  • [3] 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
    Andrade, Jason G.
    Verma, Atul
    Mitchell, L. Brent
    Parkash, Ratika
    Leblanc, Kori
    Atzema, Clare
    Healey, Jeff S.
    Bell, Alan
    Cairns, John
    Connolly, Stuart
    Cox, Jafna
    Dorian, Paul
    Gladstone, David
    McMurtry, M. Sean
    Nair, Girish M.
    Pilote, Louise
    Sarrazin, Jean-Francois
    Sharma, Mike
    Skanes, Allan
    Talajic, Mario
    Tsang, Teresa
    Verma, Subodh
    Wyse, D. George
    Nattel, Stanley
    Macle, Laurent
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (11) : 1371 - 1392
  • [4] Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention
    Andrade, Jason G.
    Krahn, Andrew D.
    Skanes, Allan C.
    Purdham, Daniel
    Ciaccia, Antonio
    Connors, Sean
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (06) : 747 - 753
  • [5] Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Batat, Erez
    Avnery, Orly
    Ellis, Martin H.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07) : 847 - +
  • [6] Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
    Bai, Ying
    Guo, Shi-Dong
    Deng, Hai
    Shantsila, Alena
    Fauchier, Laurent
    Ma, Chang-Sheng
    Lip, Gregory Y. H.
    [J]. AGE AND AGEING, 2018, 47 (01) : 9 - 17
  • [7] Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT)
    Bando, Shigenobu
    Nishikado, Akiyoshi
    Hiura, Norikazu
    Ikeda, Shuntaro
    Kakutani, Akiyoshi
    Yamamoto, Katsuhito
    Kaname, Noriyoshi
    Fukatani, Masahiko
    Takagi, Yuichiro
    Yukiiri, Kazushi
    Fukuda, Yamato
    Nakaya, Yutaka
    [J]. JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 197 - 201
  • [8] Barrios V, 2014, FUTUR CARDIOL, V10, P215, DOI [10.2217/FCA.14.2, 10.2217/fca.14.2]
  • [9] Batalla Insenser B, 2018, REV CLIN ESP, V218, P267
  • [10] Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study
    Blacher, Jacques
    Sorbets, Emmanuel
    Meynier, Dominique Guedj
    Huberman, Jean-Pierre
    Gauthier, Jacques
    Cohen, Serge
    Hoffman, Olivier
    [J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (09) : 891 - 898